AUSNUTRIA (01717) announced its full-year performance for 2024, with a net profit attributable to equity holders of 2.36 billion yuan, an increase of 35.3% year-on-year.

AUSNUTRIA (01717) announced its full-year performance for 2024, with revenue of about 7.4024 billion yuan, a year-on-year increase of 0.3%. Gross profit was approximately 3.108 billion yuan, an increase of 8.9% year-on-year. The company's net profit attributable to equity holders was 236 million yuan, an increase of 35.3% year-on-year. Basic earnings per share were 13.26 cents, with a final dividend of 0.06 Hong Kong dollars per share. Over the past year, facing a challenging environment, all employees of the company actively adhered to the AUSNUTRIA business philosophy, met challenges head-on, and Jabeite still maintained a good momentum, achieving steady growth in revenue and profit. The Haipukai brand strength continued to improve, and the team's organizational capabilities also improved. The international business saw a sudden rise, with both revenue and profit achieving high growth rates. The nutritional business gradually built core competitive advantages and achieved sustained growth. The announcement stated that profit growth was mainly driven by Jabeite's strong performance overseas and a recovery in China, as well as improvements in the global supply chain, resulting in a reduction in inventory provisions made throughout the year.